Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40
Leerink Partners analyst Will Soghikian initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Outperform rating and announces Price Target of $40.
A big investment bank analyst just started following Q32 Bio and gave it a positive rating. When a new analyst likes a company, it means they think the business looks promising and worth watching.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.